Nasdaq: PVLA
Palvella Therapeutics insiders
The officers, directors and 10% owners of Palvella Therapeutics, Inc. who hold the most stock, valued at the live PVLA price.
$145.77
PVLA today −$810K (−0.55%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their PVLA stock
- $164M
- Market value
- $2.13B
- Held by ranked insiders
- 7.70%
Insiders by value of PVLA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Wes Kaupinen | President & CEO | 825,819 | $120M | 5.65% | 1314th |
| 2 | George M. Jenkins | Director | 132,616 | $19.3M | 0.91% | 5338th |
| 3 | Todd C. Davis | Director | 112,547 | $16.4M | 0.77% | 1694th |
| 4 | Elaine J. Heron | Director | 53,691 | $7.8M | 0.37% | 6862nd |
| 5 | Matthew E. Korenberg | CFO, Treasurer | 1,000 | $146K | <0.1% | 6391st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Palvella Therapeutics; see each profile for the filing.